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Pseudomonas aeruginosa is an opportunistic pathogen that causes serious infections in immunocompromised
patients and those with cystic fibrosis (CF). This gram-negative bacterium uses multiple cell-to-cell signals to
control numerous cellular functions and virulence. One of these signals is 2-heptyl-3-hydroxy-4-quinolone,
which is referred to as the Pseudomonas quinolone signal (PQS). This signal functions as a coinducer for a
transcriptional regulator (PqsR) to positively control multiple virulence genes and its own synthesis. PQS
production is required for virulence in multiple models of infection, and it has been shown to be produced in
the lungs of CF patients infected by P. aeruginosa. One of the precursor compounds from which PQS is
synthesized is the metabolite anthranilate. This compound can be derived from the conversion of chorismate
to anthranilate by an anthranilate synthase or through the degradation of tryptophan via the anthranilate
branch of the kynurenine pathway. In this study, we present data which help to define the kynurenine pathway
in P. aeruginosa and show that the kynurenine pathway serves as a critical source of anthranilate for PQS
synthesis. We also show that the kyn pathway genes are induced during growth with tryptophan and that they
are autoregulated by kynurenine. This study provides solid foundations for the understanding of how P.
aeruginosa produces the anthranilate that serves as a precursor to PQS and other 4-quinolones.
Pseudomonas aeruginosa is an opportunistic pathogen that
can infect insects, plants, animals, and humans. This bacterium
is one of the leading nosocomial pathogens in the United
States and also causes chronic lung infections in most cystic
fibrosis (CF) patients (21, 45, 48, 50). P. aeruginosa is ubiqui-
tous in our environment and is notoriously resistant to antibi-
otics, making infections especially difficult to control and treat.
When causing an infection, P. aeruginosa utilizes numerous
virulence factors, many of which are controlled by cell-to-cell
signaling. The las and rhl quorum-sensing systems function
through the acyl-homoserine lactone intercellular signals N-(3-
oxododecanoyl) homoserine lactone and N-butyryl homo-
serine lactone, respectively (36, 37). These signals control 6 to
11% of the P. aeruginosa genome (43, 47) and are required for
virulence (see reference 8 for a review). P. aeruginosa also
produces a third signal, which was identified as 2-heptyl-3-
hydroxy-4-quinolone and is referred to as the Pseudomonas
quinolone signal (PQS) (38).
PQS has been shown to control the expression of multiple
virulence factors (9, 11, 31, 38), and it is produced by P. aerugi-
nosa in the lungs of infected CF patients (5). In addition,
quinolone signaling is required for virulence in nematodes,
plants, and mice (9, 15, 16, 24, 28, 41, 52). We have shown that
PQS acts as a coinducer for a LysR-type transcriptional acti-
vator called PqsR (also referred to as MvfR) (4, 46). In the
presence of PQS, PqsR interacts with the promoter region of
the pqsABCDE operon, which is part of the PQS synthetic gene
cluster (7, 16), thereby creating a positive feedback loop for
PQS production (46). It has also been found that 2-heptyl-4-
quinolone, which is proposed to be the direct precursor of
PQS, is capable of activating PqsR but with a potency that is
100-fold lower than that of PQS (52).
Along with PQS, P. aeruginosa produces at least 55 other
quinolone compounds, many of which were identified because
of their antibiotic activities (25, 26) (Note that PQS exhibited
no antibiotic activity [38].) Studies of the synthesis of these
compounds have shown that 4-quinolones are derived via the
condensation of anthranilate and a fatty acid (6, 42). More
specifically, we showed indirectly that anthranilate is a precur-
sor for PQS and that the addition of an anthranilate analog to
a P. aeruginosa culture would disrupt PQS production (3). In
addition, Bredenbruch et al. (2) clearly showed that carbon 4
of PQS derives from anthranilic acid and carbon 2 derives from
acetate, thereby proving that anthranilate and a fatty acid
combine to produce 2-heptyl-4-quinolone, which can then be
converted to PQS by a monooxygenase. With such compelling
evidence to support the importance of anthranilate for PQS
synthesis, it was clear that P. aeruginosa must have mechanisms
in place to ensure that enough anthranilate is available to
support both basic cellular functions and 4-quinolone synthesis.
This is supported by the fact that P. aeruginosa appears to have
multiple routes through which it can synthesize anthranilate. The
genome of this organism encodes multiple proteins that are sim-
ilar to an anthranilate synthase (www.pseudomonas.com), but
only two of these (TrpEG and PhnAB) appear to supply an-
thranilate that is available for general cellular functions (13,
14). Most interestingly, one of these anthranilate synthases
happens to be encoded by genes within the PQS synthetic
region. Adjacent to the pqsABCDE operon is the phnAB
operon, which is positively controlled by PqsR (4) and encodes
the large and small subunits, respectively, of an anthranilate
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synthase (13). In addition, the three genes (kynA, kynB, and
kynU) of the anthranilate branch of the kynurenine (kyn) path-
way, which converts tryptophan to anthranilate, are present in
P. aeruginosa (see www.pseudomonas.com). The importance of
this catabolic pathway for PQS synthesis has been suggested by
the data of D’Argenio et al. (7). We speculate that, as a key
factor in the 4-quinolone synthesis pathway, the cellular supply
of anthranilate could provide a viable drug target that if dis-
rupted would lessen the virulence of P. aeruginosa. With this in
mind, this study begins to sort out the sources of anthranilate
for PQS production and demonstrates the importance of the
kynurenine pathway for PQS biosynthesis.
MATERIALS AND METHODS
Strains and culture conditions. Bacterial strains and plasmids used in this
study are described in Table 1. P. aeruginosa strains were maintained at 70°C
in 10% skim milk and were freshly plated to begin each experiment. Bacteria
were cultured at 37°C in peptone tryptic soy broth (PTSB) (33) or Luria-Bertani
medium (LB), as noted. For experiments in minimal medium, bacteria were
cultured in low-phosphate succinate medium (LPSM) (16), which was supple-
mented with the indicated kynurenine pathway metabolites as indicated below.
Cultures were supplemented with 200 g/ml carbenicillin when necessary to
maintain plasmids.
Generation of mutant strains. Plasmid constructions were completed using
Escherichia coli cloning strains listed in Table 1. Mutant alleles were generated
using the PCR technique of splicing by overlap extension (19). Alleles were
constructed to contain in-frame deletions in the coding DNA sequence corre-
sponding to amino acids 11 to 246 for kynA (85% of protein sequence), 31 to 172
for kynB (66% of protein sequence), 36 to 377 for kynU (82% of protein se-
quence), and 45 to 499 for phnA (86% of protein sequence). Oligonucleotide
primers used for mutant construction are listed in Table 2 and were designed so
that PCR products would contain approximately 1 kb of DNA upstream or
downstream from the splice junction. Primers were synthesized with attB1 or
attB2 sequences to allow for the use of Gateway Cloning Technology (Invitro-
gen), and strain PAO1 chromosomal DNA was used as a PCR template. Once
constructed, alleles were transferred into pEXGWAp using either BP or LR
Clonase II enzyme mix (Invitrogen). Plasmids pkynAsuc, pkynBsuc2,
pkynUsuc, and pphnAsuc2 (Table 1), which carry deletion mutant alleles for
kynA, kynB, kynU, and phnA, respectively, were transformed into strain PAO1 by
electroporation (12). Mutants were selected as described by Hoang et al. (17) by
plating transformants first on medium containing carbenicillin and then on me-
dium containing 6% sucrose to remove the vector sequence. Colonies of poten-
tial mutants were screened by PCR using appropriate flanking primers, and
mutants were further confirmed by determining the DNA sequence of the PCR
products.
Feeding and complementation experiments. For experiments with radioactive
tryptophan, washed cells from overnight cultures were used to inoculate 10-ml
cultures of LB supplemented with 5 Ci L-[5-3H]tryptophan (specific activity, 32
Ci/mmol; Amersham Biosciences) to a turbidity at 660 nm (optical density at 660
nm [OD660]) of 0.05. After 24 h of growth, 300-l samples of each culture were
extracted with 900 l acidified ethyl acetate as described elsewhere (5). One-half
of the resulting organic phase was evaporated to dryness at 37°C and reconsti-
tuted in 50 l 1:1 acidified ethyl acetate-acetonitrile. Samples were analyzed by
thin-layer chromatography (TLC) and photographed under long-wave UV light
as described previously (5), and the position of PQS on the TLC plate was
marked. The plate was air dried and then treated with En3Hance spray (Perkin-
Elmer) as recommended by the manufacturer. Kodak Biomax XAR film was
exposed to the TLC plate for 4 days before development.
For complementation experiments, washed cells from overnight cultures
grown in PTSB were used to inoculate 10-ml cultures of PTSB or LB supple-
mented with 1 mM L-tryptophan (Sigma), L-kynurenine (Sigma), or anthranilic
acid (Acros) to an OD660 of 0.05. After 24 h of growth, 300-l samples of each
culture were extracted with 900 l acidified ethyl acetate. Samples were prepared
as described above and analyzed by TLC. The data presented are from cells
grown in PTSB, and there was no difference in the data when cells were grown
in LB. Experiments in which bacteria were cultured in minimal medium were
performed in the same manner, except that bacteria were grown for 30 h before
samples were collected for ethyl acetate extraction.
Construction of lacZ reporter plasmids and -galactosidase (-Gal) assays. A
kynA-lacZ reporter plasmid was constructed by using PCR to amplify a 496-bp
fragment of the kynA upstream region (412 to 84 relative to the kynA
translational start site). For this amplification, the oligonucleotide primers con-
tained XhoI and XbaI restriction sites and cosmid clone pMTP153 was used as
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant genotype or phenotype Reference orsource
Strains
E. coli
DH5 F/endA1 hsdR17 supE44 thi-1 recA1 gyrA relA1 (lacZYA-argF)U169 deoR
80dlac(lacZ)M15recA1	
51
One Shot ccdB survival T1 phage-resistant cells Invitrogen
P. aeruginosa
PAO1 Wild type 18
PA14 Wild type 40
PJF-KA1 kynA deletion mutant derived from strain PAO1 This study
PJF-KB1 kynB deletion mutant derived from strain PAO1 This study
PJF-KU1 kynU deletion mutant derived from strain PAO1 This study
PJF-PHNA1 phnA deletion mutant derived from strain PAO1 This study
S. aureus ATCC 25923 Clinical isolate; laboratory test strain ATCC
Plasmids
pEXGWAp Gateway cloning vector adapted for P. aeruginosa M. Wolfgang
pkynAsuc kynA deletion suicide vector This study
pkynBsuc2 kynB deletion suicide vector This study
pkynUsuc kynU deletion suicide vector This study
pphnAsuc2 phnA deletion suicide vector This study
pLP170 lacZ transcriptional fusion vector 39
pMTP121 Minimum tiling pathway cosmid 121 which contains kynB; Tetr 20
pMTP153 Minimum tiling pathway cosmid 153 which contains kynA; Tetr 20
pJF01 kynB-lacZ transcriptional fusion This study
pJF03 kynA-lacZ transcriptional fusion This study
pUCP22 E. coli/P. aeruginosa cloning vector 49
pJF100 phnAB complementation plasmid This study
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a source of template DNA. The amplified fragment was digested with XhoI and
XbaI, purified from an agarose gel, and ligated into pLP170 digested with the
same enzymes, to produce reporter plasmid pJF03. Similarly, a kynB-lacZ re-
porter plasmid was constructed by using PCR to amplify a 378-bp fragment of the
kynB upstream region (289 to 89 relative to the kynB translational start site).
For this amplification, the oligonucleotide primers contained XhoI and XbaI
restriction sites and cosmid clone pMTP121 was used as a source of template
DNA. The amplified fragment was digested, purified from an agarose gel, and
ligated into pLP170 digested with the same enzymes, to produce reporter plas-
mid pJF01. Both gene fusions were sequenced to ensure that mutations were not
introduced during DNA manipulations. Plasmids were transformed into P.
aeruginosa strains by electroporation (12).
For experiments to test the effects of kynurenine pathway metabolites on
kynA and kynB-lacZ expression, washed cells from overnight cultures grown in
LPSM were used to inoculate 10-ml subcultures of LPSM to an OD660 of 0.05.
Subcultures were grown for 6 hours at 37°C, and then 1-ml aliquots were trans-
ferred to tubes and supplemented with either water, 1 mM L-tryptophan, 1 mM
L-kynurenine, or 1 mM anthranilic acid. Cultures were incubated in tubes at 37°C
for 18 h, and then cells were collected by centrifugation, resuspended in fresh
LPSM, and assayed for 
-Gal activity in duplicate. Data are presented in Miller
units as the mean  the standard deviation (n  1) of four separate experiments.
Staphylococcus aureus plate killing assay. The ability of P. aeruginosa strains to
lyse S. aureus was tested as described by Mashburn et al. (29). An overnight
culture of S. aureus strain ATCC 25923 was grown in LB, diluted to an OD600 of
0.1 in fresh medium, and used to thoroughly swab an LB plate. Overnight
cultures of P. aeruginosa strains grown in LB were diluted to an OD660 of 3.0, and
2 l of each was spotted onto the freshly swabbed plate of S. aureus. The plate
was incubated for 24 h at 37°C and then photographed.
RESULTS
Tryptophan provides a PQS precursor. We have previously
shown that anthranilate is a precursor for PQS (3). In addition,
Bredenbruch et al. (2) nicely demonstrated that acylated
4-quinolone compounds are produced through the condensa-
tion of anthranilate and a 
-keto-decanoic acid. With the
knowledge that anthranilate is a precursor for PQS, it made
sense that the genes (phnAB) for the large and small subunits
of an anthranilate synthase are contained within the PQS syn-
thetic gene cluster. However, we previously reported the curi-
ous finding that some of the genes of the kynurenine pathway
were required for PQS production (7). This led us to believe
that the supply of anthranilate for PQS synthesis was derived
from at least two cellular sources. With this in mind, we began
to explore the role of the kynurenine pathway in PQS synthe-
sis. The kynurenine pathway is well characterized in eukaryotic
organisms, where it is responsible for the breakdown of tryp-
tophan into other compounds (see reference 44). Recently, it
was shown that a relatively small group of bacteria (including
P. aeruginosa) possess genes which encode proteins that are
homologous to enzymes of the kynurenine pathway (22). In P.
aeruginosa, three of these genes encode homologs of trypto-
phan 2,3-dioxygenase (KynA), N-formyl-kynurenine formami-
dase (KynB), and kynureninase (KynU), which are proposed to
convert tryptophan into anthranilate (23) (Fig. 1). Most inter-
estingly, Matthijs et al. (30) also presented data which sug-
gested that Pseudomonas fluorescens probably utilizes the
kynurenine pathway to produce quinolobactin, a quinoline
compound that acts as a siderophore. Therefore, we hypothe-
sized that tryptophan degraded via the kynurenine pathway
could serve as a precursor for PQS. To learn more about the
importance of tryptophan degradation for PQS synthesis, we
began our studies by growing P. aeruginosa strain PAO1 in the
presence of radiolabeled tryptophan in rich medium. (Note
that results did not differ between when LB was used as a
growth medium and when PTSB was used as a growth me-
dium.) After 24 h of growth with ring-labeled [3H]tryptophan,
the culture was extracted with acidified ethyl acetate and ex-
tracts were resolved by TLC to visualize PQS (Fig. 2A). The
location of PQS was marked, and the TLC plate was then dried
and exposed to X-ray film (Fig. 2B). The result of this exper-
iment showed that the growth of P. aeruginosa in the presence
of radioactive tryptophan resulted in the production of radio-
active PQS (Fig. 2A and B, lanes 2). Under our solvent con-
ditions, which have been used to purify PQS (38), tryptophan
did not migrate from the origin (Fig. 2B, lane 1). However, a
radioactive compound that corresponded to the exact location
of PQS appeared on the autoradiograph (Fig. 2B, lane 2),
indicating that PQS was radioactive and that tryptophan could
serve as a precursor for PQS. To expand on these studies, we
created P. aeruginosa isogenic, in-frame deletion mutants for
kynA, kynB, and kynU (see Materials and Methods). Each
mutant was grown in rich medium in the presence of radioac-
tive tryptophan and analyzed as described above, in order to
determine whether tryptophan conversion to PQS continued
to occur. We found that PQS production was not detected in
TABLE 2. Primers used to construct P. aeruginosa mutant strains
Primer name Sequencea
kynA upstream 1 ................................................................5-TACAAGAAAGCTGGGTGCAGGCATATCCGCTGCGGTTCCA-3
kynA upstream 2 ................................................................5-GATGATGCGCTCCACCGTGGTCACCTGGGCCTGGGAGTGAGGGCAAGG-3
kynA downstream 1 ...........................................................5-GGCGTGATCTACCTCGACGGCAACTTCACCCCGCTTTACACCCGCTTC-3
kynA downstream 2 ...........................................................5-TACAAAAAAGCAGGCTTCGACCCCCGCTGTTTCGGCTACC-3
kynB upstream 1.................................................................5-TACAAGAAAGCTGGGTGCGACGCTGGATGATCAGGTTGCG-3
kynB upstream 2.................................................................5-CACGTCGTCGAGGACCACGCCTTCCCATTCCTGCTGGAACGGCGTGTC-3
kynB downstream 1............................................................5-GACACGCCGTTCCAGCAGGAATGGGAAGGCGTGGTCCTCGACGACGTG-3
kynB downstream 2............................................................5-TACAAAAAAGCAGGCTTTCGATGAACAGATCGGCGAGGGC-3
kynU upstream 1 ................................................................5-TACAAGAAAGCTGGGTTGCAGGTGACGGAGAATGCGCAGA-3
kynU upstream 2 ................................................................5-GAAGCGGGTGTAAAGCGGGGTGAAGTTGCCGTCGAGGTAGATCACGCC-3
kynU downstream 1 ...........................................................5-GGCGTGATCTACCTCGACGGCAACTTCACCCCGCTTTACACCCGCTTC-3
kynU downstream 2 ...........................................................5-TACAAAAAAGCAGGCTGCCAGGGTCAGCAGGTAGAACACC-3
phnA upstream 1................................................................5-TACAAAAAAGCAGGCTCGCTGGTTGAAGGAGGGATCAGCC-3
phnA upstream 2................................................................5-CAGCGCCTTGTTGCGGGTTTCCTCGCAGTCGAACAGCATCCGGTTGGC-3
phnA downstream 1...........................................................5-GCCAACCGGATGCTGTTCGACTGCGAGGAAACCCGCAACAAGGCGCTG-3
phnA downstream 2...........................................................5-TACAAGAAAGCTGGGTGACATGCTGCGTCTGGTGGAAGCC-3
a att sequences are underlined.
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the kynA and kynU mutants and that the kynB mutant pro-
duced a greatly reduced amount of PQS compared to the
wild-type strain PAO1 (Fig. 2A, lanes 2 to 5). No radioactive
PQS was detected from any of the mutant strains (Fig. 2B).
Overall, these data implied that the kynurenine pathway is an
important source of anthranilate for the synthesis of PQS.
To assess the viability of the predicted kynurenine pathway
shown in Fig. 1, we grew our kyn mutants in rich medium in the
presence of either exogenous tryptophan, kynurenine, or an-
thranilic acid. After overnight growth, the cultures were ex-
tracted with acidified ethyl acetate and PQS was assayed by
TLC. The results of this experiment showed that the kynA and
kynB mutants were able to produce PQS when grown in the
presence of kynurenine and anthranilate but not when supple-
mented with tryptophan (Fig. 3A and B). In addition, the kynU
mutant was able to produce PQS when grown in the presence
of anthranilate but not when grown with tryptophan or kynure-
nine (Fig. 3B). PQS production by the wild-type strain PAO1
was not affected by any of these metabolites (Fig. 3A). (Note
that the second compound of the kynurenine pathway, N-
formyl-kynurenine, is not commercially available and was not
tested.) It should also be noted here that the organization of
the kynB and kynU genes suggests that they form an operon
(Fig. 1). Their open reading frames are separated by only three
nucleotides and are on the same strand of DNA. If this is the
case, we can be assured that our kynB mutation did not have a
polar effect on kynU, because exogenous kynurenine restored
PQS production to strain PJF-KB1 (kynB) (Fig. 3B). Taken
together, the data presented above support the model of the P.
aeruginosa kynurenine pathway shown in Fig. 1, where trypto-
FIG. 1. Predicted model of the P. aeruginosa kynurenine pathway and its relationship to PQS synthesis. In this model, anthranilate for PQS
synthesis is provided by either tryptophan degradation or the PhnAB anthranilate synthase depending on environmental conditions. The PA
numbers indicate the position of genes in the strain PAO1 genome sequence provided at www.pseudomonas.com.
FIG. 2. P. aeruginosa incorporates radioactive tryptophan into PQS. P. aeruginosa strains were grown in rich medium (LB) in the presence of
radioactive tryptophan for 24 h, and ethyl acetate extracts derived from 300 l of culture (or uninoculated medium control) were analyzed by TLC.
(A and B) Photograph (A) and autoradiograph (B) of resolved TLC plate. Lanes 1 contain 0.001 Ci L-[5-3H]tryptophan, and lanes 8 contain 25
ng synthetic PQS. Lanes 2 to 6 contain culture extracts from strains PAO1, PJF-KA1, PJF-KB1, PJF-KU1, and PJF-PHNA1, respectively. Lanes
7 contain an extract of uninoculated culture medium. (C) Autoradiograph of a resolved TLC plate containing an extract from a strain PA14 culture
grown in the presence of radioactive tryptophan. Lane 1 contains the strain PA14 culture extract, and lane 2 contains 25 ng of synthetic PQS. The
dashed circle indicates the position of synthetic PQS as determined by alignment with the corresponding TLC plate.
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phan is converted to kynurenine by KynA and KynB and
kynurenine is then converted to anthranilate by KynU. In ad-
dition, the fact that anthranilic acid restored PQS production
to all three mutants also suggested that, in rich medium, the
kynurenine pathway is the main source of anthranilate for PQS
production.
The PhnAB anthranilate synthase supplies anthranilate
during growth in minimal medium. The finding that the
kynurenine pathway was required for PQS synthesis was inter-
esting because previous data showed that one phnA mutant
(strain MP710) did not produce PQS in rich medium, while
others did produce PQS (16). Since phnA is located between
the pqsABCDE and pqsR operons in the PQS synthetic gene
cluster, it would seem logical that phnA, which encodes an
anthranilate synthase (13), would supply the anthranilate
needed for PQS synthesis. To try to understand our data, we
constructed an isogenic, in-frame phnA deletion mutant in the
same PAO1 strain which was used previously (16). Interest-
ingly, this mutant, strain PJF-PHNA1, produced PQS at a level
similar to that of the wild-type strain PAO1 (Fig. 2A, lane 6),
and it was able to convert radiolabeled tryptophan into PQS
(Fig. 2B, lane 6). We confirmed this result by using a different
suicide vector to construct a second strain PAO1 phnA dele-
tion mutant, which had a tetracycline resistance gene inserted
within phnA (data not shown). This mutant also produced PQS
at a level comparable to that of the wild-type strain (data not
shown). We then analyzed strain MP710 by PCR and Southern
blot analysis to determine the location of the tetracycline re-
sistance gene insertion. PCR amplification of chromosomal
DNA and subsequent DNA sequencing showed that the phnA
gene of MP710 was not disrupted, and Southern blot analysis
indicated that this strain most likely resulted from a spurious
recombination event that inserted a mutating plasmid within
either the pqsC or the pqsD gene (data not shown). This dis-
covery was in agreement with previous mutant complementa-
tion experiments which showed that PQS production was re-
stored to strain MP710 when it contained a plasmid harboring
pqsABCD (16). With this problem clarified, it was obvious from
the data presented above and elsewhere (7) that the kynure-
nine pathway, and not phnAB, was important for PQS synthesis
during growth in rich medium. To ensure that this effect was
not unique to strain PAO1, we tested the ability of strain PA14,
another P. aeruginosa clinical isolate that is commonly used for
research purposes, to convert tryptophan into PQS. The data
presented in Fig. 2C show that when grown in the presence of
radiolabeled tryptophan, strain PA14 produced radioactive
PQS. This indicated that the importance of the kynurenine
pathway for PQS production was not exclusive to strain PAO1.
We next assayed the ability of P. aeruginosa to produce PQS
in minimal medium in the presence or absence of tryptophan
or anthranilate. In minimal medium with succinate as a carbon
source, strain PAO1 produced PQS and this production was
increased when the medium was supplemented with trypto-
phan or anthranilate (Fig. 4, lanes 1 to 3). Unlike the result
from rich medium, the kynA mutant produced PQS in un-
supplemented succinate minimal medium (Fig. 4, lane 4). This
production did not change when the kynA mutant culture was
supplemented with tryptophan, but PQS synthesis increased
when anthranilate was added before growth (Fig. 4, lanes 5 and
6). These data implied that, in minimal medium, anthranilate
is supplied from a source other than the kynurenine pathway.
This conclusion was supported by data which showed that
strain PJF-PHNA1 did not make PQS in minimal medium
(Fig. 4, lane 7). However, PQS production returned to strain
PJF-PHNA1 when either tryptophan or anthranilate was
added to the medium (Fig. 4, lanes 8 and 9). It is also impor-
tant to note that PQS production by strain PJF-PHNA1 was
FIG. 3. Compounds from the kynurenine pathway are able to re-
store PQS production in kyn mutant strains. Ethyl acetate extracts
from cultures grown in rich medium supplemented with water (W),
L-tryptophan (T), L-kynurenine (K), or anthranilic acid (AA) were
analyzed by TLC. Equal volumes of extracts (derived from 300 l of
culture) were resolved in each lane, and the compound added to each
culture is indicated below the lane number. (A) Lanes 1 to 4 contain
extracts from strain PAO1 cultures, and lanes 5 to 8 contain extracts
from strain PJF-KA1 cultures. (B) Lanes 1 to 4 contain extracts from
strain PJF-KB1 cultures, and lanes 5 to 8 contain extracts from strain
PJF-KU1 cultures. Lane 9 of each thin-layer chromatograph contains
25 ng synthetic PQS.
FIG. 4. The phnAB operon is important for PQS production in
minimal medium. Ethyl acetate extracts from cultures grown in LPSM
supplemented with water (W), 1 mM L-tryptophan (T), or 0.5 mM
anthranilic acid (AA) were analyzed by TLC. Equal volumes of ex-
tracts were resolved in each lane, and the compound added to each
culture is indicated at the top of each lane. Lanes 1 to 3 contain
extracts from strain PAO1 cultures, lanes 4 to 6 contain extracts from
strain PJF-KA1 cultures, and lanes 7 to 9 contain extracts from strain
PJF-PHNA1 cultures. Lane 10 contains an extract from a culture of
PJF-PHNA1 carrying vector plasmid pUCP22, and lane 11 contains an
extract from a culture of PJF-PHNA1 carrying phnAB plasmid pJF100.
Lane 12 contains 25 ng of synthetic PQS, and lane 13 contains 34 ng of
anthranilic acid.
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complemented by a plasmid which contained phnAB con-
trolled by its natural promoter (Fig. 4, lane 11). It is not clear
why the amount of PQS produced by the complemented strain
was lower than that produced by the wild-type strain, but the
simplest explanation is that this was due to a negative effect
exerted by the high copy number of phnAB. Nevertheless, the
data described above suggested that phnAB supplied anthra-
nilate for PQS synthesis when tryptophan was not available
and that the kynurenine pathway was the major supplier of
anthranilate when tryptophan was present.
The expression of kynA and kynB is regulated by kynurenine.
To further explore the role of the kynurenine pathway in PQS
synthesis, we began studies of the expression of kynA and kynB.
Reporter plasmids containing either a kynA-lacZ or a kynB-
lacZ transcriptional fusion were constructed (see Materials
and Methods) and transformed into the wild-type strain PAO1
or the kynA mutant PJF-KA1. Cultures were then grown in
minimal medium in order to determine the effects of various
supplemented metabolites. For comparison, the wild-type
strain containing each plasmid was also grown in rich medium.
The results of these experiments showed that kynA and kynB
are regulated in a similar manner. Compared to their expres-
sion in rich medium, the expression of both kynA-lacZ and
kynB-lacZ decreased in minimal medium where tryptophan
and its breakdown products were absent (Fig. 5). When tryp-
tophan or kynurenine was added to minimal medium in which
the wild-type strain was grown, both the expression of kynA
and that of kynB were greatly induced (Fig. 5). However, in a
kynA mutant this large induction was not seen in the presence
of tryptophan but was seen only in the presence of kynurenine
(Fig. 5). This implied that the kynurenine pathway was posi-
tively autoregulated by kynurenine. In addition, supplementa-
tion of medium with anthranilate had no effect on kynA or
kynB transcription (Fig. 5), indicating that the cellular pool of
anthranilate does not affect the expression of kynurenine path-
way genes. Taken together, the data presented in Fig. 4 and
Fig. 5 indicate that the genes of the kynurenine pathway are
induced in the presence of tryptophan in order to provide the
anthranilate that is used in PQS synthesis.
Kynurenine pathway mutants have a reduced ability to kill
Staphylococcus aureus. To determine whether the kynurenine
pathway would affect 4-quinolone production at a level that is
biologically significant, we assayed the ability of kyn mutants to
compete with other species. P. aeruginosa possesses the ability
to kill several gram-positive bacterial species, including S.
aureus, and it has been shown elsewhere that this ability is
dependent on genes necessary for the production of PQS and
other 4-quinolone compounds (10, 29). We tested our kynure-
nine pathway mutants in order to determine whether they were
also deficient in the ability to kill S. aureus. To assay this, P.
aeruginosa strains were inoculated onto L agar plates that had
been freshly swabbed with S. aureus and the bacteria were
grown overnight. The results of this experiment showed that
the kynA and kynU mutants were unable to kill S. aureus (Fig.
6), and the kynB mutant, which produced a small amount of
PQS (Fig. 2), had a reduced ability to kill S. aureus compared
to that of the wild-type strain (Fig. 6). These data agreed with
those of Fig. 2 and demonstrated that, in strain PAO1, the
ability to degrade tryptophan was necessary for PQS and other
FIG. 5. The transcription of kynA and kynB is increased in the
presence of tryptophan or kynurenine. 
-Gal activity of a kynA-lacZ
fusion on pJF03 (A) or a kynB-lacZ fusion on pJF01 (B) in strains
PAO1 and PJF-KA1 was assayed in cultures grown in LPSM supple-
mented with either water (black bars), 1 mM L-tryptophan (checkered
bars), 1 mM L-kynurenine (light gray bars), or 1 mM anthranilic acid
(white bars) for 24 h. For reference, the striped bars represent data
derived from unsupplemented cultures grown in PTSB medium. 
-Gal
activity is presented in Miller units as the mean  n  1 of results from
duplicate assays from at least three separate experiments. As a refer-
ence, parental vector plasmid pLP170 in strain PAO1 cultured in
LPSM supplemented with water produced 814  292 Miller units of

-Gal activity.
FIG. 6. Mutants in the kynurenine pathway have a reduced ability
to lyse S. aureus. Bacteria from overnight cultures of the indicated P.
aeruginosa strains were spotted onto a plate that had been swabbed
with S. aureus. The plate was incubated for 24 h at 37°C and photo-
graphed. The figure presented is representative of data obtained from
at least four separate experiments.
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4-quinolones to be synthesized at a level which produced a
biological effect.
DISCUSSION
We have previously shown that anthranilate is a precursor of
PQS and that an anthranilate analog would inhibit PQS pro-
duction (3). This led us to propose that anthranilate and the
enzymes which produce it may serve as targets for the devel-
opment of novel therapeutic agents. With this in mind, we set
out to investigate how P. aeruginosa produces the anthranilate
that is condensed with a fatty acid to form the 4-quinolone
compound that serves as a direct precursor of PQS and other
4-quinolone compounds. In this report, we demonstrated that
the degradation of tryptophan through the kynurenine path-
way is an important source of anthranilate for PQS production.
Our data showed that supplementing a P. aeruginosa culture
with radioactive tryptophan resulted in the production of ra-
diolabeled PQS and that kynurenine pathway mutants could
not produce radioactive PQS (Fig. 2). The kynurenine pathway
is well characterized in mammals, but little is known about the
aerobic degradation of tryptophan in bacteria (see reference
23). Studies by others have shown that the P. aeruginosa KynB
homolog and the Pseudomonas fluorescens KynA homolog are
important for tryptophan degradation (23, 30). In P. aerugi-
nosa, the kynurenine pathway is proposed to function through
three enzymes (Fig. 1). Tryptophan would enter the pathway
and be converted to formyl-kynurenine by a tryptophan 2,3-
dioxygenase (KynA), and formyl-kynurenine would then be
converted to kynurenine by a kynurenine formamidase (KynB).
The final conversion of kynurenine to anthranilate would be
catalyzed by a kynureninase (KynU). Our data indicated that
kynA and kynU mutants produced no PQS and that a kynB
mutant produced a greatly reduced amount of PQS (Fig. 2).
These results are similar to those reported by D’Argenio et al.
(7), who showed that kynA and kynB were important for PQS
production in an autolytic P. aeruginosa double mutant that
overproduced PQS. We also presented data which imply that,
as expected, KynU is responsible for the conversion of kynuren-
ine to anthranilate in P. aeruginosa (Fig. 3). In addition, our
data suggested that KynA and KynB were responsible for con-
verting tryptophan to kynurenine in P. aeruginosa (Fig. 3),
which agrees with the report by Kurnasov et al. (23), who
showed that kynB from P. aeruginosa encodes a functional
kynurenine formamidase. Overall, the data presented here in-
dicated that the kynurenine pathway is a major source of the
anthranilate used to synthesize PQS.
Previously it was assumed that the anthranilate synthase
encoded by phnAB provided the majority of anthranilate for
PQS synthesis due to the fact that the phnAB operon is adja-
cent to, and coregulated with, the genes necessary for PQS
biosynthesis (10). However, evidence that an alternative path-
way may supply anthranilate has been implied by data from
multiple publications. In the first study which identified the
PhnAB anthranilate synthase, a phnA mutant continued to
produce pyocyanin (13), even though PQS is necessary for
pyocyanin production (10, 11, 16). In addition, a strain PA14
phnA mutant was able to lyse Bacillus subtilis at a level that was
approximately 70% of that seen with the parental strain, while
a strain PA14 pqsA mutant was completely attenuated in the
ability to lyse B. subtilis (35). This suggested that, unlike the
pqsA mutant, the phnA mutant was still capable of producing
the 4-quinolone compounds that were responsible for lysing
gram-positive bacteria (10, 27). It has also been suggested that
anthranilate for PQS production could be derived from an-
other functional anthranilate synthase (i.e., TrpEG) encoded
by P. aeruginosa. The TrpEG anthranilate synthase has been
shown to be responsible for producing the anthranilate needed
for tryptophan synthesis (14). While our current data do not
rule out the possibility of a role for TrpEG in PQS synthesis, it
seems that it is unlikely due to the fact that trpG is down-
regulated during stationary-phase growth, when PQS is maxi-
mally produced, and the TrpEG anthranilate synthase is inhib-
ited by tryptophan (13). Therefore, we speculate that the
results seen in these earlier publications were probably due to
tryptophan degradation through the kynurenine pathway
rather than the result of anthranilate synthesis by tryptophan
biosynthetic enzymes.
As for the role of the PhnAB anthranilate synthase in PQS
production, our data showed that a kynurenine pathway mu-
tant continued to make PQS in minimal medium (Fig. 4),
suggesting that anthranilate was being produced by an alter-
native pathway. However, a phnA mutant failed to produce
PQS when grown in minimal medium, and PQS production
was restored by the addition of either exogenous anthranilic
acid or a plasmid-borne copy of phnAB (Fig. 4). These data
indicated that the PhnAB anthranilate synthase was able to
provide sufficient anthranilate for PQS production in the ab-
sence of tryptophan or its breakdown products. It is unclear
why the PhnAB anthranilate synthase was unable to support
PQS production in our kynurenine pathway mutants when they
were cultured in rich medium, and further studies of the reg-
ulation and activity of PhnAB are necessary to determine the
specific environmental conditions which cause it to become
active. Nevertheless, the presence of two independent path-
ways that produce anthranilate that is used by P. aeruginosa for
the synthesis of 4-quinolones implies that anthranilate is an
important metabolite for the pathogenesis of P. aeruginosa.
We also began preliminary studies of the regulation of the
kyn genes in P. aeruginosa in order to gain a better understand-
ing of the role of this pathway in PQS biosynthesis. Using lacZ
reporter fusions, we found that the expression of kynA and
kynB was strongly induced in the presence of tryptophan, and
further investigation suggested that this induction was specif-
ically caused by the tryptophan breakdown product L-kynure-
nine (Fig. 5). We also found that the expression of kynA and
kynB was increased in rich medium (which contains trypto-
phan), compared to expression in minimal medium (Fig. 5),
suggesting that the kyn pathway is up-regulated to provide
anthranilate for PQS production when excess tryptophan is
present. This finding is especially interesting in light of the fact
that sputum from the lungs of CF patients has been found to
be rich in amino acids and is an excellent carbon source to
support the growth of P. aeruginosa (1, 32, 34). It is also
interesting that Palmer et al. (34) found that P. aeruginosa
strain PA14 grown in minimal medium supplemented with
tryptophan produced approximately threefold-more PQS than
when it was grown in minimal medium alone and approxi-
mately five times more PQS when grown with CF sputum as
the sole carbon source than when grown with glucose. Our data
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are in agreement with these findings and add more support to
the theory that 4-quinolone production is increased in the
amino acid-rich growth environment found in the CF patient
lung. This leads us to speculate that the kynurenine pathway
may be particularly important to support PQS production
when tryptophan is readily available, as in the lungs of CF
patients. This would make the kynurenine pathway especially
attractive to those interested in exploring novel targets for the
development of new therapeutic treatments for P. aeruginosa
infections in CF patients.
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